Medpace (NASDAQ:MEDP – Get Free Report) had its price target dropped by Robert W. Baird from $565.00 to $477.00 in a report issued on Friday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s price objective suggests a potential upside of 21.24% from the stock’s current price. A number of [...]
Robert W. Baird Cuts Medpace (NASDAQ:MEDP) Price Target to $477.00
